Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daisuke Yabe

Showing results (191-200 of 253) with videos related to

Pageof 26
Sort By:
Journal of Diabetes Research|January 21, 2016
Insulin Secretory Defect and Insulin Resistance in Isolated Impaired Fasting Glucose and Isolated Impaired Glucose ToleranceSae Aoyama-Sasabe, Mitsuo Fukushima, Xin Xin, et al.
Journal of Diabetes and Its Complications|June 9, 2016
Efficacy of lixisenatide in patients with type 2 diabetes: A post hoc analysis of patients with diverse β-cell function in the GetGoal-M and GetGoal-S trialsDaisuke Yabe, Anu Ambos, Bertrand Cariou, et al.
Diabetology International|September 19, 2022
Semaglutide is effective in type 2 diabetes and obesity with schizophreniaKaoru Noda, Takehiro Kato, Nao Nomura, et al.
Diabetes Research and Clinical Practice|September 7, 2013
Enhanced glucagon-like peptide-1 secretion in a patient with glucagonoma: implications for glucagon-like peptide-1 secretion from pancreatic α cells in vivoDaisuke Yabe, Mariyo Rokutan, Yoshiyuki Miura, et al.
Journal of Diabetes Investigation|May 21, 2014
Dipeptidyl-peptidase IV inhibitor is effective in patients with type 2 diabetes with high serum eicosapentaenoic acid concentrationsTakafumi Senmaru, Michiaki Fukui, Kanae Kobayashi, et al.
Nutrition & Diabetes|September 24, 2020
Correction: The Smart Life Stay (SLS) program: effects of a lifestyle intervention program in combination with health tourism and health guidance for type 2 diabetesMadoka Matsushita, Akiko Muramoto, Eri Nomura, et al.
Endocrine Journal|November 22, 2021
Glucokinase-maturity onset diabetes mellitus in the young suggested by factory-calibrated glucose monitoring data: a case reportNao Nomura, Katsumi Iizuka, Eiichi Goshima, et al.
Nutrition & Diabetes|August 31, 2020
The Smart Life Stay (SLS) program: effects of a lifestyle intervention program in combination with health tourism and health guidance for type 2 diabetesMadoka Matsushita, Akiko Muramoto, Eri Nomura, et al.
Journal of Diabetes Investigation|August 13, 2018
Safety and tolerability of empagliflozin in East Asian patients with type 2 diabetes: Pooled analysis of phase I-III clinical trialsDaisuke Yabe, Atsutaka Yasui, Linong Ji, et al.
Journal of Diabetes Investigation|March 2, 2018
Mental distress and health-related quality of life among type 1 and type 2 diabetes patients using self-monitoring of blood glucose: A cross-sectional questionnaire study in JapanNagaaki Tanaka, Daisuke Yabe, Kenta Murotani, et al.
Pageof 26

Showing results (191-200 of 253) with videos related to

Sort By:
Pageof 26
Journal of Diabetes Research|January 21, 2016
Insulin Secretory Defect and Insulin Resistance in Isolated Impaired Fasting Glucose and Isolated Impaired Glucose ToleranceSae Aoyama-Sasabe, Mitsuo Fukushima, Xin Xin, et al.
Journal of Diabetes and Its Complications|June 9, 2016
Efficacy of lixisenatide in patients with type 2 diabetes: A post hoc analysis of patients with diverse β-cell function in the GetGoal-M and GetGoal-S trialsDaisuke Yabe, Anu Ambos, Bertrand Cariou, et al.
Diabetology International|September 19, 2022
Semaglutide is effective in type 2 diabetes and obesity with schizophreniaKaoru Noda, Takehiro Kato, Nao Nomura, et al.
Diabetes Research and Clinical Practice|September 7, 2013
Enhanced glucagon-like peptide-1 secretion in a patient with glucagonoma: implications for glucagon-like peptide-1 secretion from pancreatic α cells in vivoDaisuke Yabe, Mariyo Rokutan, Yoshiyuki Miura, et al.
Journal of Diabetes Investigation|May 21, 2014
Dipeptidyl-peptidase IV inhibitor is effective in patients with type 2 diabetes with high serum eicosapentaenoic acid concentrationsTakafumi Senmaru, Michiaki Fukui, Kanae Kobayashi, et al.
Nutrition & Diabetes|September 24, 2020
Correction: The Smart Life Stay (SLS) program: effects of a lifestyle intervention program in combination with health tourism and health guidance for type 2 diabetesMadoka Matsushita, Akiko Muramoto, Eri Nomura, et al.
Endocrine Journal|November 22, 2021
Glucokinase-maturity onset diabetes mellitus in the young suggested by factory-calibrated glucose monitoring data: a case reportNao Nomura, Katsumi Iizuka, Eiichi Goshima, et al.
Nutrition & Diabetes|August 31, 2020
The Smart Life Stay (SLS) program: effects of a lifestyle intervention program in combination with health tourism and health guidance for type 2 diabetesMadoka Matsushita, Akiko Muramoto, Eri Nomura, et al.
Journal of Diabetes Investigation|August 13, 2018
Safety and tolerability of empagliflozin in East Asian patients with type 2 diabetes: Pooled analysis of phase I-III clinical trialsDaisuke Yabe, Atsutaka Yasui, Linong Ji, et al.
Journal of Diabetes Investigation|March 2, 2018
Mental distress and health-related quality of life among type 1 and type 2 diabetes patients using self-monitoring of blood glucose: A cross-sectional questionnaire study in JapanNagaaki Tanaka, Daisuke Yabe, Kenta Murotani, et al.
Pageof 26